Tag Archives: drugs

THE MARY JANE VELOSO STORY: NORA AUNOR TO STAR IN NEW FILM, ‘WALANG HIMALA!’

April 30, 2015 Pol Pinoy Leave a comment

MANILA, Philippines (The Adobo Chronicles) – Multi-awarded Filipino actress Nora Aunor is unstoppable. She is the lead actress in a new Filipino film that’s been accepted into this year’s prestigious Cannes Film Festival.

Brillante Ma. Mendoza’s “Taklub” is one of two films from Southeast Asia included as additional entries in the Un Certain Regard section at Cannes.

Today, Indonesia-based Bali Films announced that it has signed an agreement with Aunor to star in a new film about the true-to-life story of Filipina Mary Jane Veloso, convicted of a drug crime and sentenced to execution. Veloso was spared from the firing squad (the only one of nine convicts scheduled to be executed this week in Indonesia) which many Filipinos are calling a “miracle.”

It was of course not a miracle as pointed out in an editorial published by The Adobo Chronicles.

The new film is a sequel to Aunor’s critically acclaimed film, ‘Himala’ released in 1982.

Aunor will play the role of Veloso in this new film that revolves around the stay of execution granted to the Filipina convict. The plot maintains that there was no miracle and follows the many events that eventually led to Veloso’s being spared from the firing squad.

The script was written by The Adobo Chronicles’ lead reporter, Maharlika Mendoza.

President Aquino and his sister, Kris, will play cameo roles in the film.

Business, Health & Medicine, International, Technology

FDA APPROVES FIRST ‘SELFIE’ DRUG

March 2, 2015 Pol Pinoy Leave a comment

LENERKUSEN, NORTH RHINE-WESTPHALIA, Germany (The Adobo Chronicles) – The U.S. Food and Drug Administration (FDA) has given the green light to Bayer Pharmaceuticals for the marketing of the first drug to cure selfitis, an inflammation of the ego which last year was officially declared a mental disorder by the American Psychiatric Association.

Bayer is a German chemical and pharmaceutical company founded in Barmen, Germany in 1863. It is headquartered in Leverkusen, North Rhine-Westphalia, Germany and well is known for its original brand of aspirin.

The FDA approval came after successful Phase III clinical trials which showed the new pill’s overwhelming safety and efficacy in combatting selfies – the taking of photos of one’s self and posting them on social media.

Because selfitis has become a highly contagious worldwide epidemic, the FDA granted Bayer a fast track approval process. FDA drug approval takes takes anywhere from 10 to 15 years, but it took just 14 months for Bayer to gain the marketing green light.

The new drug comes in pill form and requires a doctor’s prescription. Dosage is different for men and women. Men need to take one pill a day while women need 5 pills. Neither Bayer nor the FDA had any explanation on the dosage discrepancy.

Bayer is now pursuing drug approval in Europe and Asia.

Health & Medicine, International, The Media

U.S. FOOD AND DRUG ADMINISTRATION APPROVES NEW PILLS TO CURE SELFITIS

August 4, 2014 Pol Pinoy Leave a comment

Washington, D.C. (The Adobo Chronicles) – The. U.S. Food and Drug Administration (FDA) today announced the approval of a new pill that would cure selfitis, the obsessive-compulsive urge to take photos of one’s self and posting them on social media.

Recently, the American Psychiatric Association (APA) officially classified selfie-taking as a mental disorder with three levels of the disease: borderline, acute and chronic.

The FDA announcement unveiled three color-coded pills that doctors can prescribe to their patients: green for borderline, blue for acute and red for chronic selfitis. In clinical trials conducted prior to the FDA approval, the pills showed an efficacy rate of plus or minus three percent.

The new pills are similar to FDA-approved drugs that fall under the category of SSRI, or selective serotonin reuptake inhibitors, used to treat depression and anxiety. The new pills’ manufacturer, Actavis which recently acquired Forest Laboratories, said the new drug will be marketed under the brand name selpram . Forest Laboratories owns the brand name Celexa (citalopram) which is prescribed for depression.

The FDA announcement came as a huge relief to selfie addicts, a population that has grown to almost 1 Billion worldwide. Equally, Facebook and Instagram users will be spared from the agony of having to deal with their friends’ selfies all too frequently posted on their walls.

Selpram will be available in the market starting this fall.